Description
Gonadorelin is a synthetic decapeptide identical in sequence to endogenous gonadotropin-releasing hormone (GnRH). It carries an N-terminal pyroglutamate and a C-terminal glycinamide.
In published literature, gonadorelin has been characterized as an agonist at the GnRH receptor (GnRHR), a class A G protein-coupled receptor. This material is supplied as a characterized reference compound for non-clinical laboratory work, such as analytical method development for amidated peptides, GnRH receptor binding and inositol phosphate or calcium-mobilization assays, comparative studies against GnRH analogues, and in vitro receptor pharmacology.
Compound Specifications
- Sequence: pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH₂
- Sequence Length: 10 residues (decapeptide)
- Molecular Formula: C₅₅H₇₅N₁₇O₁₃
- Molecular Weight: ~1182.3 g/mol
- PubChem CID: 638793
- CAS Number: 9034-40-6
- Other Designations: GnRH, LHRH, luteinizing hormone-releasing hormone, gonadoliberin
- Physical Form: Lyophilized powder
Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.
FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

